These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 11034943
1. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, Goldberg AT, Zellner JL, Crumbley AJ. Circulation; 2000 Oct 17; 102(16):1944-9. PubMed ID: 11034943 [Abstract] [Full Text] [Related]
2. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, Spinale FG. Circulation; 1998 May 05; 97(17):1708-15. PubMed ID: 9591765 [Abstract] [Full Text] [Related]
3. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Spinale FG, Coker ML, Bond BR, Zellner JL. Cardiovasc Res; 2000 May 05; 46(2):225-38. PubMed ID: 10773226 [Abstract] [Full Text] [Related]
4. Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy. Spruill LS, Lowry AS, Stroud RE, Squires CE, Mains IM, Flack EC, Beck C, Ikonomidis JS, Crumbley AJ, McDermott PJ, Spinale FG. Am J Physiol Cell Physiol; 2007 Oct 05; 293(4):C1362-73. PubMed ID: 17670887 [Abstract] [Full Text] [Related]
5. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T, Koono M, Wakisaka S. Cancer Lett; 2000 Sep 01; 157(2):177-84. PubMed ID: 10936678 [Abstract] [Full Text] [Related]
6. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. Fielitz J, Leuschner M, Zurbrügg HR, Hannack B, Pregla R, Hetzer R, Regitz-Zagrosek V. J Mol Med (Berl); 2004 Dec 01; 82(12):809-20. PubMed ID: 15558223 [Abstract] [Full Text] [Related]
7. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ. Mol Cell Biochem; 1996 Feb 09; 155(1):13-21. PubMed ID: 8717434 [Abstract] [Full Text] [Related]
8. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. Dalberg K, Eriksson E, Enberg U, Kjellman M, Bäckdahl M. World J Surg; 2000 Mar 09; 24(3):334-40. PubMed ID: 10658069 [Abstract] [Full Text] [Related]
9. Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling. Wei Y, Cui C, Lainscak M, Zhang X, Li J, Huang J, Zhang H, Zheng Z, Hu S. J Cell Mol Med; 2011 Apr 09; 15(4):773-82. PubMed ID: 20219015 [Abstract] [Full Text] [Related]
10. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis. Choi EY, Kim D, Hong BK, Kwon HM, Song YG, Byun KH, Park HY, Whang KC, Kim HS. Exp Mol Med; 2002 Dec 31; 34(6):391-400. PubMed ID: 12526080 [Abstract] [Full Text] [Related]
11. Association of matrix metalloproteinase expression and left ventricular function in idiopathic dilated cardiomyopathy. Yokoseki O, Yazaki Y, Suzuki J, Imamura H, Takenaka H, Isobe M. Jpn Circ J; 2000 May 31; 64(5):352-7. PubMed ID: 10834450 [Abstract] [Full Text] [Related]
12. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers. Norgauer J, Hildenbrand T, Idzko M, Panther E, Bandemir E, Hartmann M, Vanscheidt W, Herouy Y. Br J Dermatol; 2002 Dec 31; 147(6):1180-6. PubMed ID: 12452868 [Abstract] [Full Text] [Related]
13. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy. Schwartzkopff B, Fassbach M, Pelzer B, Brehm M, Strauer BE. Eur J Heart Fail; 2002 Aug 31; 4(4):439-4. PubMed ID: 12167381 [Abstract] [Full Text] [Related]
14. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Li YY, Feng Y, McTiernan CF, Pei W, Moravec CS, Wang P, Rosenblum W, Kormos RL, Feldman AM. Circulation; 2001 Sep 04; 104(10):1147-52. PubMed ID: 11535571 [Abstract] [Full Text] [Related]
15. Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity. Deschamps AM, Yarbrough WM, Squires CE, Allen RA, McClister DM, Dowdy KB, McLean JE, Mingoia JT, Sample JA, Mukherjee R, Spinale FG. Circulation; 2005 Mar 08; 111(9):1166-74. PubMed ID: 15723986 [Abstract] [Full Text] [Related]
16. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients. Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP. Am J Hypertens; 2004 Sep 08; 17(9):775-82. PubMed ID: 15363819 [Abstract] [Full Text] [Related]
17. Mechanical stretch induces MMP-2 release and activation in lung endothelium: role of EMMPRIN. Haseneen NA, Vaday GG, Zucker S, Foda HD. Am J Physiol Lung Cell Mol Physiol; 2003 Mar 08; 284(3):L541-7. PubMed ID: 12456388 [Abstract] [Full Text] [Related]
18. Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium. Kiczak L, Tomaszek A, Bania J, Paslawska U, Zacharski M, Janiszewski A, Rybinska I, Dziegiel P, von Haehling S, Ardehali H, Jankowska EA, Ponikowski P. J Physiol Pharmacol; 2014 Jun 08; 65(3):365-75. PubMed ID: 24930508 [Abstract] [Full Text] [Related]